GlaxoSmithKline Plc (GSK):企業の財務・戦略的SWOT分析

◆英語タイトル:GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4279FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:101
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

GlaxoSmithKline Plc (GSK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GlaxoSmithKline Plc (GSK) is a healthcare company that focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervous system (CNS), metabolic, cardiovascular and urogenital, anti-bacterials, dermatology and rare diseases. The company also offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases. GSK’s vaccine portfolio covers various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in Brentford, Middlesex, the UK.

GlaxoSmithKline Plc Key Recent Developments

Mar 19,2021: Boston Pharma signs out-licensing agreement with GSK
Mar 11,2021: GSK to expand clinical trial manufacturing capacity at CGT Catapult site in UK
Feb 18,2021: GSK, Vir expand collaboration for influenza, respiratory virus therapies
Feb 12,2021: Sandoz signs $500m deal to acquire GSK’s cephalosporin antibiotics business
Feb 04,2021: GSK and CureVac enter Covid-19 vaccine development collaboration

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
GlaxoSmithKline Plc – Key Facts
GlaxoSmithKline Plc – Key Employees
GlaxoSmithKline Plc – Key Employee Biographies
GlaxoSmithKline Plc – Major Products and Services
GlaxoSmithKline Plc – History
GlaxoSmithKline Plc – Company Statement
GlaxoSmithKline Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
GlaxoSmithKline Plc – Business Description
Business Segment: Consumer Healthcare
Overview
Performance
Key Stats
Business Segment: Pharmaceuticals
Overview
Performance
Key Stats
Business Segment: Vaccines
Overview
Performance
Key Stats
Geographical Segment: Rest of World
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
R&D Overview
GlaxoSmithKline Plc – Corporate Strategy
GlaxoSmithKline Plc – SWOT Analysis
SWOT Analysis – Overview
GlaxoSmithKline Plc – Strengths
GlaxoSmithKline Plc – Weaknesses
GlaxoSmithKline Plc – Opportunities
GlaxoSmithKline Plc – Threats
GlaxoSmithKline Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
GlaxoSmithKline Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 19, 2021: Boston Pharma signs out-licensing agreement with GSK
Mar 11, 2021: GSK to expand clinical trial manufacturing capacity at CGT Catapult site in UK
Feb 18, 2021: GSK, Vir expand collaboration for influenza, respiratory virus therapies
Feb 04, 2021: GSK and CureVac enter Covid-19 vaccine development collaboration
Feb 03, 2021: GSK delivers FY 2020 reported sales of £34 billion, +1% AER, +3% CER and Adjusted EPS of 115.9p, -6% AER, -4% CER, in line with guidance; Total EPS 115.5p, +23% AER
Jan 28, 2021: Lilly, Vir and GSK collaborate for trial of Covid-19 therapies
Jan 26, 2021: GSK ranks 1st in the 2021 Access to Medicine Index with leading R&D pipeline for priority diseases
Jan 22, 2021: Ten leading bioPharma companies announce formation of Accumulus Synergy to develop global data sharing platform
Jan 19, 2021: Novartis and GSK announce collaboration to support scientific research into genetic diversity in Africa
Jan 04, 2021: Philips and GSK partner to better inform parents about child vaccination
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
GlaxoSmithKline Plc, Key Facts
GlaxoSmithKline Plc, Key Employees
GlaxoSmithKline Plc, Key Employee Biographies
GlaxoSmithKline Plc, Major Products and Services
GlaxoSmithKline Plc, History
GlaxoSmithKline Plc, Other Locations
GlaxoSmithKline Plc, Subsidiaries
GlaxoSmithKline Plc, Joint Venture
GlaxoSmithKline Plc, Key Competitors
GlaxoSmithKline Plc, Ratios based on current share price
GlaxoSmithKline Plc, Annual Ratios
GlaxoSmithKline Plc, Annual Ratios (Cont...1)
GlaxoSmithKline Plc, Annual Ratios (Cont...2)
GlaxoSmithKline Plc, Interim Ratios
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
GlaxoSmithKline Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[GlaxoSmithKline Plc (GSK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intercept Pharmaceuticals Inc (ICPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops and commercializes treatments for non-viral, progressive liver diseases. It develops products using its proprietary bile acid chemistry. The company’s lead product candidate, obeticholic acid ( …
  • Neurimmune Holding AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurimmune Holding AG (Neurimmune), formerly Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics for human diseases. The company’s pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human neurodeg …
  • Gfk SE (GFK):企業の財務・戦略的SWOT分析
    Summary GfK SE (GfK) is a business service provider that offers market and consumer services. The company provides solutions such as online pricing intelligence, brand and customer experience, point of sales analytics, digital marketing intelligence, consumer panels, product catalogs, market opportu …
  • Ingenico SA (ING):企業の財務・戦略的SWOT分析
    Ingenico SA (ING) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Diana S.A.S.:企業の戦略・SWOT・財務分析
    Diana S.A.S. - Strategy, SWOT and Corporate Finance Report Summary Diana S.A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Canpotex Ltd:企業の戦略的SWOT分析
    Canpotex Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Dr. Reddy’s Research and Development BV-医療機器分野:企業M&A・提携分析
    Summary Dr. Reddy’s Research and Development BV (Dr. Reddy’s Research and Development), a subsidiary of Dr. Reddy's Laboratories Ltd is a drug formulation and manufacturing service provider that develops and manufactures improved injectable pharmaceuticals. The company offers services such as formul …
  • Celularity Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Celularity Inc (Celularity) is a biotechnology company that develops and commercializes therapeutics derived from the placenta for autoimmune and degenerative diseases, immuno-oncology, and functional regeneration. The company’s pre-clinical and clinical assets include CAR-T cell receptor an …
  • Energa SA (ENG):企業の財務・戦略的SWOT分析
    Energa SA (ENG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Harley-Davidson, Inc.:企業の戦略・SWOT・財務情報
    Harley-Davidson, Inc. - Strategy, SWOT and Corporate Finance Report Summary Harley-Davidson, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fortune Electric Co Ltd (1519):企業の財務・戦略的SWOT分析
    Summary Fortune Electric Co Ltd (Fortune Electric) is a power company that manufactures and markets transformers and accessories. The company provides products such as distribution transformers, power transformers, cast resin transformers and amorphous metal alloy core transformers, among others. It …
  • Dentsu Inc. (4324):企業の財務・戦略的SWOT分析
    Dentsu Inc. (4324) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Ekarat Engineering (Public) Co., Ltd. (AKR):企業の財務・戦略的SWOT分析
    Ekarat Engineering (Public) Co., Ltd. (AKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Dexus Property Group:企業のM&A・事業提携・投資動向
    Dexus Property Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dexus Property Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Tokyo Gas Co Ltd (9531):電力:M&Aディール及び事業提携情報
    Summary Tokyo Gas Co Ltd (Tokyo Gas) is a gas utility that produces, supplies and markets liquefied natural gas (LNG). It also produces, supplies and sells electricity. Tokyo Gas also has overseas upstream, midstream and downstream businesses. It provides engineering solutions, gas appliances and ga …
  • ImmusanT Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ImmusanT Inc (ImmusanT) is a clinical stage biotechnology company that discovers, develops and delivers peptide-based immune therapies for the treatment of patients with autoimmune diseases. The company develops its therapeutic vaccines using its epitope-specific immuno-therapy (ESIT) platfo …
  • BPL Global LLC:企業の戦略的SWOT分析
    BPL Global LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Rentech Inc (RTKH)-エネルギー分野:企業M&A・提携分析
    Summary Rentech, Inc. (Rentech) is a provider of wood fibre processing services, wood chips and wood pellets. It offers a wide range of integrated wood fibre services such as wood chipping, trading, vessel loading, operations, and marketing through its subsidiary, Fulghum Fibres, primarily to the pu …
  • University of Oxford:企業のM&A・事業提携・投資動向
    University of Oxford - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Oxford Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Morrison & Foerster LLP:企業の戦略的SWOT分析
    Morrison & Foerster LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆